Circulating tumor cells and detection of EGFR mutation in cell-free tumor DNA in blood plasma in metastatic non-small cell lung cancer with EGFR mutation.

被引:0
|
作者
Isobe, K.
Hata, Y.
Sakaguchi, S.
Sato, K.
Sugino, K.
Sano, G.
Sakamoto, S.
Takai, Y.
Shibuya, K.
Takagi, K.
Homma, S.
机构
[1] Toho Univ, Omori Med Ctr, Dept Resp Med, Tokyo, Japan
[2] Toho Univ, Omori Med Ctr, Dept Chest Surg, Tokyo, Japan
[3] Toho Univ, Omori Med Ctr, Dept Resp Med, Tokyo, Japan
[4] Toho Univ, Omori Med Ctr, Dept Pathol, Tokyo, Japan
关键词
D O I
10.1200/jco.2011.29.15_suppl.7595
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7595
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer
    Bulbul, Ajaz
    Leal, Alessandro
    Husain, Hatim
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2877 - 2882
  • [12] Circulating tumor cells and evaluation of targeted therapy effect in EGFR mutation/ALK translocation metastatic non-small cell lung cancer.
    Su, ChunXia
    Li, Xuefei
    Ren, Shengxiang
    Gao, Guanghui
    Li, Wei
    Zhao, Jing
    Chen, Xiaoxia
    Zhao, Chao
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [13] Tumor volume determines the feasibility of cell-free DNA sequencing for mutation detection in non-small cell lung cancer
    Ohira, Tatsuo
    Sakai, Kazuko
    Matsubayashi, Jun
    Kajiwara, Naohiro
    Kakihana, Masatoshi
    Hagiwara, Masaru
    Hibi, Masaaki
    Yoshida, Koichi
    Maeda, Junichi
    Ohtani, Keishi
    Nagao, Toshitaka
    Nishio, Kazuto
    Ikeda, Norihiko
    CANCER SCIENCE, 2016, 107 (11) : 1660 - 1666
  • [14] Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation
    Cho, Min-Sun
    Park, Chul Hwan
    Lee, Sungsoo
    Park, Heae Surng
    PLOS ONE, 2020, 15 (03):
  • [15] EGFR Clonality and Tumor Mutation Burden (TMB) by Circulating Tumor DNA (ctDNA) Sequencing in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ai, X.
    Lin, Y.
    Zhang, J.
    Xie, C.
    Liu, A.
    Hu, X.
    Zhao, Q.
    Zang, Y.
    Rao, C.
    Hu, X.
    Chang, L.
    Li, Q.
    Guan, Y.
    Chen, R.
    Yi, X.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S412 - S413
  • [16] Cell-Free Tumor DNA (ctDNA) Utility in Detection and Monitoring EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, J.
    Kasymjanova, G.
    Papadakis, A.
    Small, D.
    Sakr, L.
    Pepe, C.
    Wang, H.
    Cohen, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1035 - S1035
  • [17] Detection of T790M Mutation in Circulating Free Tumor DNA of Patients with EGFR-Positive Advanced Non-Small Cell Lung Cancer
    Veccia, A.
    Girlando, S.
    Dipasquale, M.
    Barbareschi, M.
    Caffo, O.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
  • [18] Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer
    Kim, Jeong-Oh
    Shin, Jung-Young
    Kim, Seo Ree
    Shin, Kab Soo
    Kim, Joori
    Kim, Min-Young
    Lee, Mi-Ran
    Kim, Yonggoo
    Kim, Myungshin
    Hong, Sook Hee
    Kang, Jin Hyoung
    CANCERS, 2020, 12 (04)
  • [19] Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC)
    Guo, Dan
    Yang, Liang
    Yang, Jianwei
    Shi, Ke
    MEDICINE, 2020, 99 (26) : E20431
  • [20] Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer
    Wan, Rui
    Wang, Zhijie
    Lee, J. Jack
    Wang, Shuhang
    Li, Qingqing
    Tang, Fuchou
    Wang, Jin
    Sun, Yu
    Bai, Hua
    Wang, Di
    Zhao, Jun
    Duan, Jianchun
    Zhuo, Minglei
    An, Tongtong
    Wu, Meina
    Chen, Zhaoli
    Yang, Zhenlin
    Wang, Jie
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1376 - 1387